These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 413889)

  • 1. [32P] diphosphonate dose determination in patients with bone metastases from prostatic carcinoma.
    Potsaid MS; Irwin RJ; Castronovo FP; Prout GR; Harvey WJ; Francis MD; Tofe AJ; Zamenhof RG
    J Nucl Med; 1978 Jan; 19(1):98-104. PubMed ID: 413889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative efficacy of 32P and 89Sr in palliation in skeletal metastases.
    Nair N
    J Nucl Med; 1999 Feb; 40(2):256-61. PubMed ID: 10025832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carcinoma of the prostate: the treatment of bone metastases by radioactive phosphorus (32P).
    Ariel IM; Hassouna H
    Int Surg; 1985; 70(1):63-6. PubMed ID: 4019087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Radioactive substances (32P and 89Sr) in the treatment of pain in bone metastases].
    Flamm J; Burkert S
    Z Urol Nephrol; 1981 Nov; 74(11):801-6. PubMed ID: 6172913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [186Re]HEDP in the palliation of painful bone metastases from cancers other than prostate and breast.
    Minutoli F; Herberg A; Spadaro P; Restifo Pecorella G; Baldari S; Aricò D; Altavilla G; Baldari S
    Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):355-62. PubMed ID: 17043634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re-186(Sn) HEDP for treatment of painful osseous metastases: initial clinical experience in 20 patients with hormone-resistant prostate cancer.
    Maxon HR; Schroder LE; Thomas SR; Hertzberg VS; Deutsch EA; Scher HI; Samaratunga RC; Libson KF; Williams CC; Moulton JS
    Radiology; 1990 Jul; 176(1):155-9. PubMed ID: 1693784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase 1 study of rhenium-186-HEDP in patients with bone metastases originating from breast cancer.
    de Klerk JM; van het Schip AD; Zonnenberg BA; van Dijk A; Quirijnen JM; Blijham GH; van Rijk PP
    J Nucl Med; 1996 Feb; 37(2):244-9. PubMed ID: 8667053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone pain palliation with 85Sr therapy.
    Giammarile F; Mognetti T; Blondet C; Desuzinges C; Chauvot P
    J Nucl Med; 1999 Apr; 40(4):585-90. PubMed ID: 10210217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of toxicity and efficacy of 186Re-hydroxyethylidene diphosphonate in patients with painful bone metastases of prostate or breast cancer.
    Kolesnikov-Gauthier H; Carpentier P; Depreux P; Vennin P; Caty A; Sulman C
    J Nucl Med; 2000 Oct; 41(10):1689-94. PubMed ID: 11037999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of rhenium-186-etidronate in prostate cancer patients with metastatic bone pain.
    Quirijnen JM; Han SH; Zonnenberg BA; de Klerk JM; van het Schip AD; van Dijk A; ten Kroode HF; Blijham GH; van Rijk PP
    J Nucl Med; 1996 Sep; 37(9):1511-5. PubMed ID: 8790203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Marrow toxicity of 33P-versus 32P-orthophosphate: implications for therapy of bone pain and bone metastases.
    Goddu SM; Bishayee A; Bouchet LG; Bolch WE; Rao DV; Howell RW
    J Nucl Med; 2000 May; 41(5):941-51. PubMed ID: 10809212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Palliative treatment of painful disseminated bone metastases with 186Rhenium-HEDP in patients with lung cancer.
    Leondi AH; Souvatzoglou MA; Rapti AS; Leontopoulou SA; Papadaki EK; Datseris EI; Anagnostopoulou US; Zerva CJ
    Q J Nucl Med Mol Imaging; 2004 Sep; 48(3):211-9. PubMed ID: 15499295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The treatment of painful osseous metastases with phosphorus-32-labeled phosphates.
    Silberstein EB
    Semin Oncol; 1993 Jun; 20(3 Suppl 2):10-21. PubMed ID: 7684860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
    Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
    Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of thrombocytopenia in patients treated with rhenium-186-HEDP: guidelines for individual dosage recommendations.
    de Klerk JM; van het Schip AD; Zonnenberg BA; van Dijk A; Stokkel MP; Han SH; Blijham GH; van Rijk PP
    J Nucl Med; 1994 Sep; 35(9):1423-8. PubMed ID: 8071686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radionuclide therapy for painful bone metastases. An Italian multicentre observational study. Writing Committee of an Ad Hoc Study Group.
    Piffanelli A; Dafermou A; Giganti M; Colamussi P; Pizzocaro C; Bestagno M;
    Q J Nucl Med; 2001 Mar; 45(1):100-7. PubMed ID: 11456368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiotherapy for painful bone metastases from hepatocellular carcinoma.
    Seong J; Koom WS; Park HC
    Liver Int; 2005 Apr; 25(2):261-5. PubMed ID: 15780048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow absorbed dose of rhenium-186-HEDP and the relationship with decreased platelet counts.
    de Klerk JM; van Dieren EB; van het Schip AD; Hoekstra A; Zonnenberg BA; van Dijk A; Rutgers DH; Blijham GH; van Rijk PP
    J Nucl Med; 1996 Jan; 37(1):38-41. PubMed ID: 8543998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosimetry of 188Re-hydroxyethylidene diphosphonate in human prostate cancer skeletal metastases.
    Liepe K; Hliscs R; Kropp J; Runge R; Knapp FF; Franke WG
    J Nucl Med; 2003 Jun; 44(6):953-60. PubMed ID: 12791825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of distant iodine-negative metastases of thyroid cancer with 32P].
    Drozdovskiĭ BI; Proshin VV
    Vopr Onkol; 1996; 42(3):71-2. PubMed ID: 8801747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.